These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22038505)

  • 1. Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.
    Atkins HL; Geier MS; Prisciandaro LD; Pattanaik AK; Forder RE; Turner MS; Howarth GS
    Dig Dis Sci; 2012 Mar; 57(3):713-9. PubMed ID: 22038505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats.
    Geier MS; Butler RN; Giffard PM; Howarth GS
    Int J Food Microbiol; 2007 Mar; 114(3):267-74. PubMed ID: 17150273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic and synbiotic fructooligosaccharide administration fails to reduce the severity of experimental colitis in rats.
    Geier MS; Butler RN; Giffard PM; Howarth GS
    Dis Colon Rectum; 2007 Jul; 50(7):1061-9. PubMed ID: 17429712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-intestinal manifestations of dextran sulfate sodium consumption in rats and assessment of the effects of Lactobacillus fermentum BR11.
    Geier MS; Smith CL; Butler RN; Howarth GS
    Dig Dis Sci; 2009 Jun; 54(6):1222-8. PubMed ID: 19005763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice.
    Sun MC; Zhang FC; Yin X; Cheng BJ; Zhao CH; Wang YL; Zhang ZZ; Hao HW; Zhang TH; Ye HQ
    J Food Sci; 2018 Oct; 83(10):2645-2652. PubMed ID: 30216448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystine uptake prevents production of hydrogen peroxide by Lactobacillus fermentum BR11.
    Hung J; Cooper D; Turner MS; Walsh T; Giffard PM
    FEMS Microbiol Lett; 2003 Oct; 227(1):93-9. PubMed ID: 14568153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystathionine gamma-lyase is a component of cystine-mediated oxidative defense in Lactobacillus reuteri BR11.
    Lo R; Turner MS; Barry DG; Sreekumar R; Walsh TP; Giffard PM
    J Bacteriol; 2009 Mar; 191(6):1827-37. PubMed ID: 19124577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats.
    Smith CL; Geier MS; Yazbeck R; Torres DM; Butler RN; Howarth GS
    Nutr Cancer; 2008; 60(6):757-67. PubMed ID: 19005975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.
    Abimosleh SM; Lindsay RJ; Butler RN; Cummins AG; Howarth GS
    Dig Dis Sci; 2012 Apr; 57(4):887-96. PubMed ID: 22147247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
    Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J
    Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grape seed extract reduces the severity of selected disease markers in the proximal colon of dextran sulphate sodium-induced colitis in rats.
    Cheah KY; Bastian SE; Acott TM; Abimosleh SM; Lymn KA; Howarth GS
    Dig Dis Sci; 2013 Apr; 58(4):970-7. PubMed ID: 23143736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional LPxTG-motif surface protein derived from Limosilactobacillus reuteri SH 23 in DSS-induced ulcerative colitis of mice.
    Zong M; Chang C; Anjum R; Xu H; Guo Y; Pan D; Wu Z
    FASEB J; 2023 May; 37(5):e22895. PubMed ID: 37000564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice.
    Ahl D; Liu H; Schreiber O; Roos S; Phillipson M; Holm L
    Acta Physiol (Oxf); 2016 Aug; 217(4):300-10. PubMed ID: 27096537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus plantarum AN1 cells increase caecal L. reuteri in an ICR mouse model of dextran sodium sulphate-induced inflammatory bowel disease.
    Yokota Y; Shikano A; Kuda T; Takei M; Takahashi H; Kimura B
    Int Immunopharmacol; 2018 Mar; 56():119-127. PubMed ID: 29414641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial Heat Shock Proteins Mediate the Protective Effects of
    Liu HY; Gu F; Zhu C; Yuan L; Zhu C; Zhu M; Yao J; Hu P; Zhang Y; Dicksved J; Bao W; Cai D
    Front Immunol; 2022; 13():865982. PubMed ID: 35320932
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang G; Huang S; Cai S; Yu H; Wang Y; Zeng X; Qiao S
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751784
    [No Abstract]   [Full Text] [Related]  

  • 17. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
    Garrido-Mesa N; Utrilla P; Comalada M; Zorrilla P; Garrido-Mesa J; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
    Biochem Pharmacol; 2011 Dec; 82(12):1891-900. PubMed ID: 21930116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions.
    Schreiber O; Petersson J; Phillipson M; Perry M; Roos S; Holm L
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G534-42. PubMed ID: 19147805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
    Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
    J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction.
    Dicksved J; Schreiber O; Willing B; Petersson J; Rang S; Phillipson M; Holm L; Roos S
    PLoS One; 2012; 7(9):e46399. PubMed ID: 23029509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.